Breast cancer cells depend on CPT1A for FAO and, in turn, activate NF-κB signaling in a lysine acetyltransferase 2a-dependent manner through p65 acetylation, conferring metastatic characteristics [94]. Here, CPT1A is linked to breast cancer.